Wittouck Amaury
Insider CIK 1841311 · WW 10% owner · LXRX Director, 10% owner · GLYC 10% owner · CAVA Director, 10% owner · SEER 10% owner · SRRK 10% owner · OMGA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CAVA CAVA GROUP, INC. | S Sale | 2026-06-15 | 2026-06-17 | 3,000,000 | $90.30 | $270.90M | 6,507,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-04-30 | 2026-05-08 | 408,435 | — | $0 | 408,435 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-04-30 | 2026-05-08 | 408,435 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-04-30 | 2026-05-08 | 20,421,735 | — | $0 | 175,156,062 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2026-02-17 | 2026-02-19 | 41,290 | $65.00 | $2.68M | 408,435 | SEC↗ |
| CAVA CAVA GROUP, INC. | S Sale | 2024-11-18 | 2024-11-20 | 8,000,000 | $134.13 | $1.07B | 9,507,990 | SEC↗ |
| CAVA CAVA GROUP, INC. | S Sale | 2024-08-26 | 2024-08-28 | 6,000,000 | $116.36 | $698.16M | 17,507,990 | SEC↗ |
| CAVA CAVA GROUP, INC. | S Sale | 2024-06-05 | 2024-06-07 | 3,000,000 | $87.25 | $261.75M | 23,507,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-05-10 | 2024-05-14 | 1,150,922 | $108.50 | $124.88M | 1,150,922 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-05-10 | 2024-05-14 | 1,150,922 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-05-10 | 2024-05-14 | 57,546,100 | — | $0 | 136,180,481 | SEC↗ |
| CAVA CAVA GROUP, INC. | S Sale | 2024-03-21 | 2024-03-25 | 2,000,000 | $66.25 | $132.50M | 26,507,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2024-03-13 | 2024-03-13 | 1,150,922 | $108.50 | $124.88M | 1,150,922 | SEC↗ |
| CAVA CAVA GROUP, INC. | S Sale | 2024-02-27 | 2024-02-29 | 3,500,000 | $53.60 | $187.60M | 28,507,990 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-10-12 | 2023-10-16 | 10,150 | $8.55 | $86.8K | 11,259,438 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-10-12 | 2023-10-16 | 2,189,781 | $6.85 | $15.00M | 11,249,288 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise deriv | 2023-06-20 | 2023-06-22 | 861,339 | — | $0 | 0 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise deriv | 2023-06-20 | 2023-06-22 | 1,568,865 | — | $0 | 0 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise deriv | 2023-06-20 | 2023-06-22 | 3,486,366 | — | $0 | 0 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise deriv | 2023-06-20 | 2023-06-22 | 1,845,864 | — | $0 | 0 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise deriv | 2023-06-20 | 2023-06-22 | 22,252,464 | — | $0 | 0 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise deriv | 2023-06-20 | 2023-06-22 | 1,993,092 | — | $0 | 0 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise | 2023-06-20 | 2023-06-22 | 861,339 | — | $0 | 7,762,434 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise | 2023-06-20 | 2023-06-22 | 1,993,092 | — | $0 | 32,007,990 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise | 2023-06-20 | 2023-06-22 | 1,845,864 | — | $0 | 6,901,095 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise | 2023-06-20 | 2023-06-22 | 3,486,366 | — | $0 | 5,055,231 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise | 2023-06-20 | 2023-06-22 | 1,568,865 | — | $0 | 1,568,865 | SEC↗ |
| CAVA CAVA GROUP, INC. | M Exercise | 2023-06-20 | 2023-06-22 | 22,252,464 | — | $0 | 30,014,898 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-05 | 2023-06-05 | 27,775,050 | $2.60 | $72.22M | 78,634,381 | SEC↗ |
| WW WW INTERNATIONAL, INC. | S Sale | 2023-05-10 | 2023-05-11 | 14,818,300 | $7.15 | $105.95M | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-04-28 | 2023-05-02 | 31,557 | $6.43 | $202.9K | 9,059,507 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-24 | 2023-02-28 | 100,000 | $1.70 | $170.0K | 8,589,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-23 | 2023-02-23 | 200,000 | $1.75 | $350.0K | 8,489,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-22 | 2023-02-23 | 150,000 | $1.79 | $268.5K | 8,289,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-21 | 2023-02-23 | 50,000 | $1.85 | $92.5K | 8,139,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-17 | 2023-02-17 | 200,000 | $1.71 | $342.0K | 8,089,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-16 | 2023-02-17 | 315,266 | $1.68 | $529.6K | 7,889,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-15 | 2023-02-17 | 1,000,000 | $2.16 | $2.16M | 7,573,798 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-09 | 2023-02-13 | 11,451 | $3.24 | $37.1K | 6,573,798 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2023-01-09 | 2023-01-11 | 1,094 | $9.48 | $10.4K | 9,027,950 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-01-05 | 2023-01-09 | 48,774 | $9.33 | $455.1K | 9,029,044 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2022-10-25 | 2022-10-27 | 130,265 | $8.04 | $1.05M | 8,980,270 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2022-10-04 | 2022-10-07 | 66,000 | $7.89 | $520.7K | 8,850,005 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2022-10-03 | 2022-10-07 | 33,971 | $7.03 | $238.8K | 8,784,005 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2022-08-05 | 2022-08-09 | 2,426,070 | $2.50 | $6.07M | 50,859,331 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2022-08-01 | 2022-08-01 | 16,173,800 | $2.50 | $40.43M | 48,433,261 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 5,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-03 | 1,323,530 | — | $0 | 1,398,530 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-03 | 875,000 | $17.00 | $14.88M | 2,273,530 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-07-30 | 2021-08-03 | 75,000 | $16.14 | $1.21M | 75,000 | SEC↗ |
| SEER Seer, Inc. | S Sale | 2021-02-01 | 2021-02-03 | 252,545 | $64.15 | $16.20M | 5,588,366 | SEC↗ |